Abstract

BackgroundClinical evidence of intraductal dissemination through the pancreatic duct has been rare. We herein describe a case of ampullary carcinoma that disseminated in the remnant pancreas through the pancreatic duct.Case presentationA 68-year-old woman underwent SSPPD for ampullary carcinoma. The tumor was diagnosed as adenocarcinoma without lymph node metastasis (T2N0M0, stage IB). Computed tomography (CT) performed 3 years later revealed a 14-mm tumor near the site of the pancreaticojejunal anastomosis. Endoscopic ultrasound-guided fine needle aspiration showed adenocarcinoma that was morphologically similar to the specimen from the first surgery. We diagnosed recurrence of ampullary carcinoma in the remnant pancreas. A total remnant pancreatectomy was performed. We found a white solid tumor at the 20-mm distal side of pancreaticojejunal anastomosis. The tumor was morphologically similar and immunostaining showed a pattern identical to that of the original tumor, suggesting that the two tumors were of the same origin.ConclusionThe recurrent lesion was most likely the result of tumor cells leaving the tumor and implanting in the remnant pancreatic duct epithelium. Intraductal dissemination of adenocarcinoma is thought to be a cause of remnant recurrence after SSPPD in cases of obstruction of the pancreatic duct or an iatrogenic procedure.

Highlights

  • Clinical evidence of intraductal dissemination through the pancreatic duct has been rare

  • We describe a case of ampullary carcinoma that disseminated and implanted in the remaining pancreas through the pancreatic duct after subtotal stomach preserving pancreatoduodenectomy (SSPPD)

  • Laboratory findings were notable for carcinoembryonic antigen (CEA) level within normal limits; carbohydrate antigen 19-9 (CA19-9) level was slightly high (65.9 U/mL), and liver enzyme levels were elevated: aspartate aminotransferase, 155 IU/L; alanine aminotransferase, 98 IU/L; γ-glutamyl transpeptidase, 1620 IU/ L; alkaline phosphatase, 1980 IU/L; and total-bilirubin, 5.3 mg/dL

Read more

Summary

Conclusion

The recurrent lesion was most likely the result of tumor cells leaving the tumor and implanting in the remnant pancreatic duct epithelium.

Background
Discussion
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.